Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
The rights issue of units that was announced on 24 August 2022 (the "Rights Issue") in Qlife Holding AB ("Qlife" or the "Company") has been registered with the Swedish Companies Registration Office (Sw. Bolagsverket) and paid subscribed units (BTU) will be replaced by shares and warrants series TO 2022. The last day for trading with BTU is 8 November 2022, and the stop date with Euroclear Sweden AB is 10 November 2022, whereafter shares and warrants will be booked in each shareholder's VP account/depository on 14 November 2022. The warrants will be traded with ISIN code SE0018690141 and the first day for trading is expected to be 14 November 2022.
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE.
Advisers
Zonda Partners AB is financial advisor and Setterwalls Advokatbyrå AB is legal advisor to Qlife in connection with the Rights Issue. Eminova Fondkommission AB is the Company's issuing agent in connection with the Rights Issue.
The information was submitted for publication, through the agency of the contact person set out above, on 2 November 2022 at 18:00 CET.